Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Toxicol Sci ; 61(1): 40-8, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11294972

RESUMO

Diindolylmethane (DIM) is an acid-catalyzed condensation product of indole-3-carbinol, a constituent of cruciferous vegetables, and is formed in the stomach. DIM alters estrogen metabolism and inhibits carcinogen-induced mammary tumor growth in rodents. DIM is a weak agonist for the aryl hydrocarbon (Ah) receptor and blocks the effects of estrogens via inhibitory Ah receptor-estrogen receptor cross-talk. DIM and various structural analogs were examined in H295R cells for effects on 3 cytochrome P450 (CYP) enzymes involved in estrogen synthesis and/or metabolism: CYP1A1, CYP1B1, and CYP19 (aromatase). Aromatase activity was measured by conversion of 1 beta-(3)H-androstenedione to estrone and (3)H(2)O. H295R cells were exposed to the test chemicals dissolved in dimethyl sulfoxide for 24 h prior to analyses. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) (0--30 nM) and DIM (0--10 microM) induced ethoxyresorufin-O-deethylase (EROD) activity, as a measure of CYP1A1 and possibly 1B1 activity, with EC(50) values of about 0.3 nM and 3 microM, respectively. DIM, but not TCDD, induced aromatase activity with an apparently maximal 2-fold increase at 10 microM; higher concentrations of DIM and many of its analogs were cytotoxic. TCDD (30 nM) significantly increased CYP1A1 and 1B1 mRNA levels, but had no effect on mRNA for CYP19. DIM (3 microM) significantly increased mRNA levels for all three CYPS: DIM analogs with substitutions on the 5 and 5' position (3 microM) induced aromatase and EROD activity, together with mRNA levels of CYP1A1, 1B1, and 19; analogs that were substituted on the central carbon of the methane group showed little or no inductive activity toward the CYPS: In conclusion, DIM and several of its analogs appear to induce CYPs via multiple yet distinct pathways in H295R human adrenocortical carcinoma cells.


Assuntos
Carcinoma Adrenocortical/enzimologia , Carcinoma Adrenocortical/metabolismo , Aromatase/efeitos dos fármacos , Hidrocarboneto de Aril Hidroxilases , Citocromo P-450 CYP1A1/efeitos dos fármacos , Sistema Enzimático do Citocromo P-450/efeitos dos fármacos , Indução Enzimática , Indóis/química , Indóis/farmacologia , Dibenzodioxinas Policloradas/farmacologia , Receptores de Hidrocarboneto Arílico/antagonistas & inibidores , Córtex Suprarrenal/enzimologia , Córtex Suprarrenal/metabolismo , Aromatase/análise , Inibidores da Aromatase , Linhagem Celular , Sobrevivência Celular , Citocromo P-450 CYP1A1/análise , Citocromo P-450 CYP1A1/antagonistas & inibidores , Citocromo P-450 CYP1B1 , Inibidores das Enzimas do Citocromo P-450 , Relação Dose-Resposta a Droga , Formazans/análise , Humanos , Indóis/síntese química , Radioisótopos do Iodo , RNA Mensageiro/biossíntese , Radioimunoensaio , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Relação Estrutura-Atividade , Sais de Tetrazólio/análise , Trítio , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA